HK1257588A1 - 預防和治療肺纖維化的藥物及其用途 - Google Patents

預防和治療肺纖維化的藥物及其用途

Info

Publication number
HK1257588A1
HK1257588A1 HK18116707.0A HK18116707A HK1257588A1 HK 1257588 A1 HK1257588 A1 HK 1257588A1 HK 18116707 A HK18116707 A HK 18116707A HK 1257588 A1 HK1257588 A1 HK 1257588A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
lung fibrosis
treating lung
treating
Prior art date
Application number
HK18116707.0A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257588A1 publication Critical patent/HK1257588A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116707.0A 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途 HK1257588A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257588A1 true HK1257588A1 (zh) 2019-10-25

Family

ID=62656674

Family Applications (5)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途

Family Applications Before (3)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途

Country Status (2)

Country Link
CN (5) CN108210897A (zh)
HK (5) HK1257589A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917335B (zh) * 2018-09-20 2023-06-27 华中科技大学同济医学院附属同济医院 Erdr1在预防和治疗纤维化疾病中的用途
CN115427066A (zh) * 2020-02-06 2022-12-02 泰伦基国际有限公司 一种预防和治疗多发性硬化症的方法和药物
KR20220143913A (ko) * 2020-02-26 2022-10-25 탈렌젠 인터내셔널 리미티드 혈압 이상 병증의 예방 및 치료 방법과 약물
CN113925022A (zh) * 2021-10-22 2022-01-14 莫汉有 一种系统性红斑狼疮并动脉粥样硬化动物模型构建方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
HUE024916T2 (en) * 2007-11-29 2016-02-29 Grifols Therapeutics Inc Recombinantly modified plasmin
MX2012000475A (es) * 2009-07-10 2012-03-26 Thrombogenics Nv Variantes de plasminogeno y plasmina.
CN101628113B (zh) * 2009-08-18 2012-01-04 南京农业大学 蚯蚓纤溶酶抗肝纤维化的应用
US20120114652A1 (en) * 2010-05-03 2012-05-10 Abbott Laboratories Anti-pai-1 antibodies and methods of use thereof
EP2822654B1 (en) * 2012-03-09 2019-08-28 Vascular Biosciences Orally active, cell-penetrating homing peptide and methods of using same
KR101467109B1 (ko) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Ｂｉｘ02189 화합물을 유효성분으로 포함하는 폐섬유증 예방 또는 치료용 조성물
KR20160035077A (ko) * 2013-08-13 2016-03-30 사노피 플라스미노겐 활성인자 저해제-1(pai-1)에 대한 항체 및 그의 용도
TWI592426B (zh) * 2013-08-13 2017-07-21 賽諾菲公司 胞漿素原活化素抑制劑－１（ｐａｉ－１）之抗體及其用途
WO2015026494A2 (en) * 2013-08-20 2015-02-26 Trustees Of Dartmouth College Methods for treating tissue fibrosis

Also Published As

Publication number Publication date
CN108210905A (zh) 2018-06-29
CN108210899A (zh) 2018-06-29
HK1257584A1 (zh) 2019-10-25
CN108210897A (zh) 2018-06-29
CN108210910A (zh) 2018-06-29
HK1257585A1 (zh) 2019-10-25
HK1257589A1 (zh) 2019-10-25
CN108210892A (zh) 2018-06-29
HK1257587A1 (zh) 2019-10-25

Similar Documents

Publication Publication Date Title
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
HK1258396A1 (zh) 用於治療纖維化的賽尼克韋羅聯合療法
IL250960A0 (en) Combined treatment of sinecriviroc for the treatment of leprosy
EP3303634A4 (en) CASE VARIANTS9 AND METHODS OF USE THEREOF
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
IL271117B (en) Diazabicyclic mutated imidazopyrimidines and their use in the treatment of respiratory disorders
IL260771B1 (en) Catheter closure solution and catheter closure treatment
LT3262037T (lt) Naujas chinolino darinys, skirtas panaudoti virusinių infekcijų gydymui ir prevencijai
IL265955A (en) Therapeutic compounds and methods of use thereof
IL265881A (en) Inhaler and methods of use thereof
HK1257588A1 (zh) 預防和治療肺纖維化的藥物及其用途
GB201617064D0 (en) Compounds and their therapeutic use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
HK1257236A1 (zh) 預防和治療高脂血症的藥物及其用途
GB201715194D0 (en) Compounds and their therapeutic use
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
HUE050456T2 (hu) Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
HK1257586A1 (zh) 預防和治療腎纖維化的藥物及其用途
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
EP3377062C0 (en) AMINONAPHHOQUINONE COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
EP3490604C0 (en) MEDICATION FOR THE TREATMENT AND/OR PREVENTION OF ENDOMETRIOSIS
PL3327201T3 (pl) Pojemnik i jego zastosowanie